Viridian Therapeutics, Inc.\DE — All Filings
773 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001193125-25-095008 | Apr 25, 2025 | Jun 20, 2025 |
| DEFA14A | DEFA14A | 0001193125-25-095018 | Apr 25, 2025 | — |
| ARS | ARS | 0001193125-25-095022 | Apr 25, 2025 | Dec 31, 2024 |
| SCHEDULE 13G | — | 0001641172-25-003888 | Apr 11, 2025 | — |
| 3 | 3 | 0000950170-25-052524 | Apr 9, 2025 | Apr 7, 2025 |
| 4 | 4 | 0000950170-25-052530 | Apr 9, 2025 | Apr 7, 2025 |
| 8-K | 8-K | 0001193125-25-073937 | Apr 7, 2025 | Apr 2, 2025 |
| 4 | 4 | 0000950170-25-037965 | Mar 12, 2025 | Mar 10, 2025 |
| 3 | 3 | 0000950170-25-037980 | Mar 12, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-038004 | Mar 12, 2025 | Mar 10, 2025 |
| 3 | 3 | 0000950170-25-037958 | Mar 12, 2025 | Mar 10, 2025 |
| 8-K | 8-K | 0001193125-25-050880 | Mar 10, 2025 | Mar 5, 2025 |
| 4 | 4 | 0000950170-25-032887 | Mar 4, 2025 | Mar 3, 2025 |
| 8-K | 8-K | 0001193125-25-044406 | Mar 4, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-032891 | Mar 4, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-032884 | Mar 4, 2025 | Mar 3, 2025 |
| 4 | 4 | 0000950170-25-032908 | Mar 4, 2025 | Mar 3, 2025 |
| 424B5 | 424B5 | 0001193125-25-044400 | Mar 4, 2025 | — |
| S-8 | S-8 | 0001193125-25-044166 | Mar 3, 2025 | — |
| 10-K | 10-K | 0001590750-25-000004 | Mar 3, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001193125-25-037586 | Feb 27, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-004228 | Feb 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-004435 | Jan 10, 2025 | Jan 7, 2025 |
| 8-K | 8-K | 0001193125-24-279021 | Dec 16, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119344 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119033 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-258738 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119339 | Nov 14, 2024 | — |
| 10-Q | 10-Q | 0001590750-24-000023 | Nov 12, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001193125-24-255130 | Nov 12, 2024 | — |
| 4 | 4 | 0000950170-24-110485 | Sep 30, 2024 | Sep 27, 2024 |
| 4 | 4 | 0000950170-24-110484 | Sep 30, 2024 | Sep 27, 2024 |
| SC 13D/A | SC 13D/A | 0001104659-24-100768 | Sep 17, 2024 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-100769 | Sep 17, 2024 | Sep 13, 2024 |
| 424B5 | 424B5 | 0001193125-24-218405 | Sep 13, 2024 | — |
| 8-K | 8-K | 0001193125-24-218131 | Sep 12, 2024 | Sep 11, 2024 |
| 424B5 | 424B5 | 0001193125-24-216641 | Sep 10, 2024 | — |
| 8-K | 8-K | 0001193125-24-216321 | Sep 10, 2024 | — |
| S-8 | S-8 | 0001193125-24-198865 | Aug 12, 2024 | — |
| 10-Q | 10-Q | 0001590750-24-000019 | Aug 8, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0001193125-24-196513 | Aug 8, 2024 | — |
| 8-K | 8-K | 0001193125-24-178820 | Jul 15, 2024 | — |
| 4 | 4 | 0000950170-24-079044 | Jun 28, 2024 | Jun 26, 2024 |
| 4 | 4 | 0000950170-24-079042 | Jun 28, 2024 | Jun 26, 2024 |
| 4 | 4 | 0000950170-24-079084 | Jun 28, 2024 | Jun 26, 2024 |
| 4 | 4 | 0000950170-24-079037 | Jun 28, 2024 | Jun 26, 2024 |
| 4 | 4 | 0000950170-24-079038 | Jun 28, 2024 | Jun 26, 2024 |
| 8-K | 8-K | 0001193125-24-164461 | Jun 20, 2024 | Jun 17, 2024 |
| DEFA14A | DEFA14A | 0001193125-24-157914 | Jun 10, 2024 | — |
| 10-Q | 10-Q | 0001590750-24-000012 | May 8, 2024 | Mar 31, 2024 |